Glenn P. Prives, a partner in the firm’s Healthcare and Corporate Departments, will be a presenter for a live webinar on “Due Diligence in Healthcare Private Equity Transactions: Minimizing Regulatory, Corporate Practice of Medicine and Other Risks,” to be presented by Strafford Publications on Tuesday, July 7, 2020 from 1:00pm – 2:30pm (ET).
This webinar will guide counsel in healthcare private equity transactions on due diligence measures that effectively identify and mitigate risks and liabilities. The program will address the regulatory and corporate practice of medicine issues that should be considered during the due diligence process.
Private equity firms play an active role in healthcare deals. As with any healthcare deal, the parties involved in healthcare private equity transactions should conduct thorough due diligence before closing the deal. The parties should consider potential successor liability, pending or threatened litigation, current contracts that could trigger penalties, and more. Because healthcare entities are highly regulated, parties to these transactions should conduct significant healthcare regulatory due diligence.
Counsel should also review current ownership structures to minimize the risk of corporate practice of medicine issues. Other regulatory considerations during the due diligence process include compliance with Stark Law, Anti-Kickback Statute, False Claims Act, and HIPAA, as well as the state law equivalents.
Speakers for this webinar will discuss the legal issues to address in healthcare due diligence, including key healthcare risk areas and requirements, compliance programs, Medicare/Medicaid changes of ownership, licenses, and permits. The panel will offer best practices for conducting due diligence in healthcare transactions.
Topics will include:
- Due diligence structure and implementation
- Legal issues/risks to address
- Successor liability
- Pending or threatened litigation
- Compliance program
- Medicare/Medicaid CHOW
- Best practices
The speakers will review these and other high-risk issues:
- What hurdles do counsel encounter when involving private equity firms in healthcare transactions?
- What are the critical regulatory due diligence issues in healthcare private equity transactions?
- What are the most effective processes for conducting due diligence in a timely and cost-effective manner?
Mr. Prives concentrates his practice in the areas of healthcare and corporate law. He represents a wide range of healthcare clients, including for-profit and not-for-profit hospitals and health systems, academic medical centers, physician groups, ambulatory surgery centers, home health agencies, ancillary service providers, laboratories, medical technology companies, telemedicine companies, medical billing companies, dental groups, skilled nursing facilities, behavioral health centers, healthcare management companies, and investment funds and private equity firms specializing in healthcare.
Additional program details and registration at: Due Diligence in Healthcare Private Equity Transactions